Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Den nuværende pris på Moderna Inc på markedet er 942,29 kr. med en 24-timers handelsvolumen på 10,61B kr.. Aktivets markedsværdi er 376,25B kr., efter at have bevæget sig -1.67% i løbet af det seneste døgn.
Tokeniseret Moderna Inc handles til 939,18 kr. med en tokeniseret markedsværdi på 7,87M kr. og en 24-timers handelsvolumen på 41,79M kr.. Det tokeniserede aktiv har flyttet sig 67.00% i de seneste 24 timer.